MarketPeel
Pricing
…
President and CEO
Stanley C. Erck
Thu, Mar 10, 2022
Mar 10
received an award in
NVAX
62,211
shares @ $0.00
New position
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NVAX
NOVAVAX INC
Health Care
Biotechnology
1D
0.00%
1W
+8.92%
1M
+17.83%
3M
-15.97%
6M
—
1Y
—
Recent insider activity at NVAX
Dec 31
James F. Young
Sold
$43.20k
Dec 24
James F. Young
Sold
$39.01k
Dec 13
Rachel K. King
Sold
$37.44k
Jun 21
James F. Young
Sold
$105.67k
Jun 18
James F. Young
Sold
$87.07k
Jun 18
James F. Young
Sold
$15.81k
Jun 17
Filip Dubovsky
Sold
$180.75k
Jun 17
Filip Dubovsky
Sold
$20.41k
Full NVAX profile →
Stanley C. Erck’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback